Cationic nanocarriers as potent adjuvants for recombinant S-RBD vaccine of SARS-CoV-2

Signal Transduct Target Ther. 2020 Dec 11;5(1):291. doi: 10.1038/s41392-020-00434-x.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / chemistry*
  • COVID-19 / genetics
  • COVID-19 / immunology*
  • COVID-19 / prevention & control
  • COVID-19 / virology
  • Cations / chemistry
  • Cations / immunology
  • Chitosan / chemistry
  • Chitosan / immunology
  • Drug Carriers / chemistry
  • Fatty Acids, Monounsaturated / chemistry
  • Fatty Acids, Monounsaturated / immunology
  • Humans
  • Polyethyleneimine / chemistry
  • Quaternary Ammonium Compounds / chemistry
  • Quaternary Ammonium Compounds / immunology
  • SARS-CoV-2 / drug effects
  • SARS-CoV-2 / immunology*
  • SARS-CoV-2 / pathogenicity
  • Spike Glycoprotein, Coronavirus / antagonists & inhibitors
  • Spike Glycoprotein, Coronavirus / immunology
  • Vaccines, Synthetic / chemistry
  • Vaccines, Synthetic / immunology
  • Viral Vaccines / chemistry
  • Viral Vaccines / immunology*

Substances

  • Adjuvants, Immunologic
  • Cations
  • Drug Carriers
  • Fatty Acids, Monounsaturated
  • Quaternary Ammonium Compounds
  • Spike Glycoprotein, Coronavirus
  • Vaccines, Synthetic
  • Viral Vaccines
  • spike protein, SARS-CoV-2
  • Polyethyleneimine
  • Chitosan
  • 1,2-dioleoyloxy-3-(trimethylammonium)propane